Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Nuria González-Rojas"'
Autor:
Antoni Sicras-Mainar, Soledad Velasco-Velasco, Josep Ramón Llopart-López, Nuria González-Rojas Guix, Chenco Clemente-Igeño, Ruth Navarro-Artieda
Publikováno v:
Revista Española de Salud Pública, Vol 82, Iss 3, Pp 315-322 (2008)
Fundamento. La hipertensión arterial (HTA) es uno de los principales motivos de consulta de los centros de atención primaria (AP). El objetivo del estudio fue determinar la asociación entre el grado de control de la HTA, la comorbilidad y los cost
Externí odkaz:
https://doaj.org/article/0e1425deebd44370865ea1b5919fb18b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luz María Peña-Longobardo, Nuria González-Rojas, Manuel Quintana, Stéphane Soulard, Covadonga Torres, M.A. Casado, M. Yébenes, Juan Oliva-Moreno, José Alvarez-Sabín, Jaime Masjuan, Javier Mar, Virginia Becerra
Publikováno v:
Stroke. 49:140-146
Background and Purpose— The aim of this article was to analyze the likelihood of receiving informal care after a stroke and to study the burden and risk of burnout of primary caregivers in Spain. Methods— The CONOCES study is an epidemiological,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6a1e24359186a2c72cdb0fcfe7f5c9
https://doi.org/10.1161/strokeaha.117.017575
https://doi.org/10.1161/strokeaha.117.017575
Autor:
Lucilla Piccari, Gabor Kovacs, Steve Jones, Hall Skaara, Claudia Roca Herms, Gabriela Silvina Bacchini Jeanneret, Melquiades Calzado Vinardell, Nuria Gonzalez‐Rojas Guix, Miriam Fernandez Delgado, Héctor Gálvez García, David Schwicker
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Pulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe, chronic, progressive condition. Yet little is known of the lived experiences, perspect
Externí odkaz:
https://doaj.org/article/f0afdccc6efb47f1b9f7ca5dac0a0c41
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Objective The aim of this study is to assess the cost-effectiveness of other long-acting muscarinic antagonist + long-acting β2 agonist combinations in comparison with Spiolto® Respimat® (tiotropium + olodaterol fixed-dose combination [FDC]) for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e75337ddd7bf4810b99b85e9ada70b
http://europepmc.org/articles/PMC5106216
http://europepmc.org/articles/PMC5106216
Autor:
Lucas M.A. Goosens, Andrew Ternouth, Marc Miravitlles, Carl Selya-Hammer, Valentina Acciai, Michael Baldwin, Nasuh Büyükkaramikli, Nuria González-Rojas Guix, Maureen P.M.H. Rutten-van Mölken
Publikováno v:
Therapeutic Advances in Respiratory Disease, 10(5), 391-401. SAGE Publications Ltd
Therapeutic Advances in Respiratory Disease, Vol 10 (2016)
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 10 (2016)
Therapeutic Advances in Respiratory Disease
Background: The objective of this study was to compare the cost-effectiveness of the fixed-dose combination (FDC) of tiotropium + olodaterol Respimat® FDC with tiotropium alone for patients with chronic obstructive pulmonary disease (COPD) in the It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd493a12917494b8bd85917c1ad10ad
http://www.scopus.com/inward/record.url?scp=84988354895&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=84988354895&partnerID=8YFLogxK
Autor:
Jaime Masjuan, Virginia Becerra, Javier Mar, M. Yébenes, Nuria González-Rojas, Covadonga Torres, Juan Oliva-Moreno, Manuel Quintana, José Alvarez-Sabín
Publikováno v:
The European Journal of Health Economics. 18:449-458
Stroke is a major social and health problem. However, since the recent incorporation of new advances in its management, little is known about the cost of stroke. The aim of this study is to find out the real cost of stroke in Spain. This is an epidem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c74631c72550f441720906d0550b8f
https://doi.org/10.1007/s10198-016-0799-9
https://doi.org/10.1007/s10198-016-0799-9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Iñigo Lechuga-Duran, Nuria González-Rojas, Antonia Gonzalez-Henares, Carlos López-Pablo, Miguel Gallofre-Lopez, Ramón Bosch-Príncep, Anna Panisello-Tafalla, Jorgina Lucas-Noll, Jose Luis Clua-Espuny, Cristina Calduch-Noll, Lluisa Queralt-Tomas, Rosa Ripolles-Vicente
Publikováno v:
Cardiology Research
Background : Atrial fibrillation (AF) is the most common cardiac tachyarrhythmia encountered in clinical practice affecting up to 10% of the population over 60 years old and its prevalence rises with age. The main goals were to characterize the AF pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41171e38fca183852be451868df9e65b
http://europepmc.org/articles/PMC5358274
http://europepmc.org/articles/PMC5358274
Autor:
Albert Roso-Llorach, Nuria González-Rojas, Emmanuel Giménez-Garcia, Carles López-Pablo, Miquel Gallofré López, Josep Lluís Clua-Espuny, Jorgina Lucas-Noll, Anna Panisello-Tafalla, Ramón Bosch-Príncep, Iñigo Lechuga-Duran, Lluïsa Queralt-Tomas
Publikováno v:
Revista Española de Cardiología (English Edition). 66:545-552
Introduction and objectives: Atrial fibrillation constitutes a serious public health problem because it can lead to complications. Thus, the management of this arrhythmia must include not only its treatment, but antithrombotic therapy as well. The ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66410a7c4a1d52ef7461eba953f65fca
https://doi.org/10.1016/j.rec.2013.03.003
https://doi.org/10.1016/j.rec.2013.03.003